Corrigendum to: "Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells"

Hossein Majidzadeh1,2,3, Mostafa Araj-Khodaei2,4, Ayuob Aghanejad1

  • 1Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.

Toxicology Reports
|March 3, 2025
PubMed